VAERS reports by lot

Pfizer COVID-19 lot FW1330: VAERS reports

57 VAERS reports list lot FW1330 as a Pfizer COVID-19 vaccine, received between 2022-08-18 and 2024-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
57
Reports
2%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular2730%
General / Systemic (non-local)1517%
Neurological1112%
Gastrointestinal1011%
Thrombotic / Hematological67%
Allergic / Anaphylactic67%
Injection-site / Local reaction44%
Respiratory33%
Dermatological (non-injection-site)33%
Musculoskeletal22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia12
Texas10
New Mexico6
Washington5
Illinois4
Wisconsin4
Nevada4
Ohio4
Virginia1
Missouri1
Tennessee1
North Carolina1

Reports by month received

2022-081
2022-097
2022-105
2022-112
2022-123
2023-0111
2023-031
2023-047
2023-0515
2023-064
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.